SV Investment is a South Korea-based venture capital firm that focuses on innovative investments in small and medium-sized venture companies across diverse sectors such as IT, healthcare, biotechnology, and cultural entertainment. Their strategy involves acquiring meaningful stakes, often aiming to be the second-largest shareholder, to provide proactive support and foster global competitiveness and scalability for their portfolio companies.
40% of their portfolio is in Biotech & Life Sciences. They made 1 investments in the last 12 months. Their most common stage is series-a (40% of deals). Average disclosed round size is $22.2M (across 9 rounds with reported amounts).
Portfolio
10
Fund Size
$1.2B
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| BBreezeBio | Series B | — | Feb 2026 |
 Avelos Therapeutics | Series B | $12.3M | Apr 2024 |
 Aniai | Series A | $12M | Jan 2024 |
 Myrealtrip | Series F | $56.7M | Jan 2024 |
| MMaka Motors | Seed | $37.6M | Jul 2023 |
 Oculii | Series B | $55M | May 2021 |
 Zeto, Inc. | Series A | $7.3M | Mar 2020 |
 Axiom Exergy | Series A | $7.6M | May 2018 |
 EpiBiome | Series A | $6M | Feb 2016 |
| AANA Therapeutics | Seed | $5M | — |
Top Co-Investors
Last updated: 4 May 2026